Bioengineer uses nanoparticles to target drugs
October 8, 2009Clemson bioengineer Frank Alexis is designing new ways to target drugs and reduce the chances for side effects.
Pharmaceutical commercials can cause the unsettling feeling that if the disease doesn't kill, the cure will, what with a drug's long list of side effects and warnings. Many therapeutic drugs administered by pill, cream, syringe, IV or liquid can be a hit or miss delivery system.
Researchers report that only 1 of 100,000 molecules of an intravenous drug make it to the intended spot in the body.
"The big issues for making medicines more effective are getting drugs to where they are needed and keeping them from breaking down as they circulate through the body," said Alexis. "A way to improve targeting a drug and preventing it from be passed out of the body is putting it in envelopes — putting the drug inside something to protect it until it's at the right spot."
The envelopes Alexis uses are nanoparticles. Think of an M&M, with the nanoparticle being the hard outer candy shell and the chocolate being the medicine. The goal would be the same as for an M&M — to melt in the right place.
Nanotechnology operates on the molecular level. It involves engineering materials on such a small scale that the results can be seen only with electron and atomic force microscopes. Nano-engineers take advantage of natural forces — positive and negative electrical charges, attraction and repulsion, surface texture — to have materials self assemble.
"You would be surprised how we mimic what nature does," said Alexis. It is setting off a storm of innovations in many fields — biology, medicine, material science, computers, manufacturing, physics.
"Nanoparticles can be modified many ways," said Alexis. "They can be coated so that they can be durable and stable. They can be patterned so that they match up like a key and a lock to connect to certain cells, tissues and organs. Some drugs are not taken up because of their physical and chemical properties."
A handful of nanoparticle medicines already have been approved for use treating diseases, particularly cancers. Alexis and other bioengineers are ushering in a new era in medicine.
A challenge for oral medicines, for example, is getting them to do some good before the body destroys them. A patient's metabolism can do its job too well taking a drug out of circulation.
Called "first-pass metabolism," the liver breaks down a drug during its first trip circulating through the body. The result is doctors must use greater amounts of oral medicines to achieve the therapeutic effect. Negative reactions from the higher doses or the inconvenience from prolonged treatment cause many patients to stop taking their medicines.
Nanoparticles can be made to survive the first pass. The particles also can be made to get beyond the body's immune system. Multi-layers on the nanoparticles or nanoshells can resist the body's defenses, enabling the medicine to last longer or reach the intended location.
Dendrimers are nanoparticles that could become the Swiss Army knives of targeted drug delivery. The particles can be made so that a number of different kinds of molecules could be attached to it. One group of molecules could fight the disease, another could enhance images to track the drug, a third could carry a chemical trigger to release the medicine by command from outside the body, another, still, that could send signals about results.
"We are moving ahead in nanoscience in laboratories throughout the world," said Alexis. "Nanoparticle functionalities become more and more complex and the next step is for the research to develop technologies allowing their transfer from the research bench to a pharmaceutical drug. New ways of targeting drugs that will be more effective and safe and more agreeable to patients is just over the horizon."
-
Nanoparticles research aids drug development
Nov 10, 2008 |
not rated yet |
0
-
Gold nanoparticles for controlled drug delivery
Dec 30, 2008 |
not rated yet |
0
-
Nano World: 150 nanodrugs on horizon
Nov 02, 2005 |
not rated yet |
0
-
Nanoparticles improve delivery of medicines and diagnostics
Apr 10, 2007 |
not rated yet |
0
-
Stealth particles to target tumors
Aug 31, 2005 |
not rated yet |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (30) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (3) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Of microchemistry and molecules: Electronic microfluidic device synthesizes biocompatible probes
Jan 26, 2012 |
5 / 5 (1) |
0
-
Pertubance in a model
5 hours ago
-
Cancer drugs and Alzheimer's, Oh my!
13 hours ago
-
Squishing cells
14 hours ago
-
Any books/articles for evolutionary stable strategy models in humans?
Feb 09, 2012
-
Science behind the bore feeling?
Feb 09, 2012
-
Homo Sapien vs. Chimpanzee - Divergence Timeline
Feb 09, 2012
- More from Physics Forums - Biology
More news stories
What lies beneath: Mapping hidden nanostructures
The ability to diagnose and predict the properties of materials is vital, particularly in the expanding field of nanotechnology. Electron and atom-probe microscopy can categorize atoms in thin sheets of material, ...
3 hours ago |
5 / 5 (1) |
1
'Dark plasmons' transmit energy
Microscopic channels of gold nanoparticles have the ability to transmit electromagnetic energy that starts as light and propagates via "dark plasmons," according to researchers at Rice University.
20 hours ago |
5 / 5 (6) |
1
|
New kind of solar cell could capture significantly more energy than current cells
New solar cells could increase the maximum efficiency of solar panels by over 25%, according to scientists from the University of Cambridge.
Feb 08, 2012 |
4.5 / 5 (12) |
14
|
Nanoshell whispering galleries improve thin solar panels
Visitors to Statuary Hall in the U.S. Capitol Building may have experienced a curious acoustic feature that allows a person to whisper softly at one side of the cavernous, half-domed room and for another on ...
Nanotechnology / Nanomaterials
Feb 07, 2012 |
4.3 / 5 (6) |
6
|
Nanotube therapy takes aim at breast cancer stem cells
Wake Forest Baptist Medical Center researchers have again proven that injecting multiwalled carbon nanotubes (MWCNTs) into tumors and heating them with a quick, 30-second laser treatment can kill them.
Nanotechnology / Bio & Medicine
Feb 09, 2012 |
5 / 5 (1) |
0
|
Hovering not hard if you're top-heavy, researchers find
Top-heavy structures are more likely to maintain their balance while hovering in the air than are those that bear a lower center of gravity, researchers at New York University's Courant Institute of Mathematical Sciences ...
Grass to gas: Researchers' genome map speeds biofuel development
Researchers at the University of Georgia have taken a major step in the ongoing effort to find sources of cleaner, renewable energy by mapping the genomes of two originator cells of Miscanthus x giganteus, a large perenn ...
Drug halts organ damage in inflammatory genetic disorder
A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease ...
Cochlear implants may be safe, effective for organ transplant patients
Cochlear implants may be a safe, effective option for some organ transplant patients who've lost their hearing as an unfortunate consequence of their transplant-related drug regime, researchers report.
Researchers develop new method for creating tissue engineering scaffolds
Researchers at Northwestern University have developed a new method for creating scaffolds for tissue engineering applications, providing an alternative that is more flexible and less time-intensive than current technology.
Molecular profiling reveals differences between primary and recurrent ovarian cancers
There is a need to analyze tumor specimens at the time of ovarian cancer recurrence, according to a new study published in Molecular Cancer Therapeutics. Researchers used a diagnostic technology called molecular profiling to examine ...